Fibroids & Endometriosis

Get information on the Clinical Trial

Women ages 18-50 with Uterine Fibroids and/or Endometriosis can participate in this study to evaluate the safety and efficacy of Elagolix in Combination with Combined Oral Contraceptives. For premenopausal females 18-50 years of age and not pregnant or planning to become pregnant in the near future. Need a documented diagnosis of fibroids and/or endometriosis that can be done as part of the study.

First name * The 'First name' field is required

Last name * The 'Last name' field is required

Email address * Please enter a valid Email address

Telephone

Message